Concepedia

Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial

Michael P. Manns, Didier Samuel, Edward Gane, David Mutimer, Geoffrey W. McCaughan, M. Prieto, José Luís Calleja, Markus Peck‐Radosavljevic, Beat Müllhaupt, Kosh Agarwal,

The Lancet Infectious Diseases · 2016 · 446 citations · 14 references

DOIFull text

Open access

Concepts

References

14

EASL Recommendations on Treatment of Hepatitis C 2018

Jean–Michel Pawlotsky, Francesco Negro, Alessio Aghemo et al. · Journal of Hepatology · 2018 · 2.8K citations

, , +14

Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic Fibrosis

Bart J. Veldt, Jordan J. Feld, Heiner Wedemeyer et al. · JAMA · 2012 · 1.5K citations · Full text

, , +17

EASL Recommendations on Treatment of Hepatitis C 2015

Journal of Hepatology · 2015 · 1.2K citations

, , +14

The Survival Benefit of Liver Transplantation

Robert M. Merion, Doulglas E. Schaubel, Dawn M. Dykstra et al. · American Journal of Transplantation · 2005 · 868 citations · Full text

, , +11

Ledipasvir and Sofosbuvir Plus Ribavirin for Treatment of HCV Infection in Patients With Advanced Liver Disease

Michael Charlton, Gregory T. Everson, Steven L. Flamm et al. · Gastroenterology · 2015 · 799 citations · Full text

, , +17